retatrutide for addiction and the Grey Market: Buyer Beware – Sarah Hormachea A review of an investigational

Retatrutide Research Peptide (GLP3-R) Lyophilized Format 99% HPLC Purity COA Available Ships in 12 Business Days U.S

Retatrutide is an investigational injectable medication currently under clinical development for the treatment of obesity and type 2 diabetes

Last updated 10/2025

14-15 It is important to note that obesity is a chronic disease, and discontinuing semaglutide can lead to weight regain due to a decrease in lean mass and basal metabolic rate (BMR)

From there, the dose strategy becomes the next layer: standard-dose semaglutide, standard-dose tirzepatide, microdose semaglutide, or microdose tirzepatide